MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.427 ◽

2017 ◽

Vol 12 (1) ◽

pp. S378-S379 ◽

Author(s):

Young Kim ◽

Toyoaki Hida ◽

Hiroshi Nokihara ◽

Masashi Kondo ◽

Koichi Azuma ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

EXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdx091.066 ◽

2017 ◽

Vol 28 ◽

pp. ii51

Author(s):

L. Horn ◽

Y.-L. Wu ◽

M. Reck ◽

C. Liang ◽

F. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Phase Iii ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Phase Iii Study ◽

Download Full-text

Phase III Study of Crizotinib Versus Pemetrexed or Docetaxel Chemotherapy in Patients with Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC) (Profile 1007)

Annals of Oncology ◽

10.1016/s0923-7534(20)34338-6 ◽

2012 ◽

Vol 23 ◽

pp. ixe21 ◽

Author(s):

A.T. Shaw ◽

D.W. Kim ◽

K. Nakagawa ◽

T. Seto ◽

L. Crinò ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Alk Positive ◽

Docetaxel Chemotherapy

Download Full-text

First-line crizotinib versus pemetrexed–cisplatin or pemetrexed–carboplatin in patients (pts) with advanced ALK-positive non-squamous non-small cell lung cancer (NSCLC): results of a phase III study (PROFILE 1014)

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8002 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8002-8002 ◽

Author(s):

Tony Mok ◽

Dong-Wan Kim ◽

Yi-Long Wu ◽

Benjamin J. Solomon ◽

Kazuhiko Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70422-6 ◽

2007 ◽

Vol 2007 ◽

pp. 206-207

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽

10.1055/s-2008-1074239 ◽

2008 ◽

Vol 62 (S 2) ◽

Author(s):

J von Pawel ◽

M Reck ◽

R Ramlau ◽

J Jassem ◽

P Zatloukal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120004.586903 ◽

2008 ◽

Author(s):

Daniel Vorobiof ◽

Keo Tabane

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13649956.15438060 ◽

2012 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Reply to the article “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study”, by Groen et al. (Ann Oncol 2004; 15: 427–432)

Annals of Oncology ◽

10.1093/annonc/mdh323 ◽

2004 ◽

Vol 15 (8) ◽

pp. 1298-1299

Author(s):

B. Jeremic

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

C3-03: Randomized, phase III Study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283204.17566.c5 ◽

2007 ◽

Vol 2 (8) ◽

pp. S365-S366 ◽

Author(s):

Kimihide Yoshida ◽

Hisao Uejima ◽

Miyako Satouchi ◽

Shinzoh Kudoh ◽

Kazuhiko Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage ◽

Phase Iii Study

Download Full-text